RubrYc Therapeutics Completes $10M Million Series A Financing

RubrYc Therapeutics, Inc., a biotherapeutics discovery business, announced today it has closed a $10 million Series A Preferred Equity financing round led by Third Point Ventures, with participation by Paladin Capital Group and Vital Venture Capital.

• Source: prnewswire
• 934
• April 16, 2018